FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.
about
A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemiaApoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoproteinImpact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing ratsInsight on Mutation-Induced Resistance from Molecular Dynamics Simulations of the Native and Mutated CSF-1R and KITAbl family kinases regulate FcγR-mediated phagocytosis in murine macrophagesPreliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexedA potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion.Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis.Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2Differential effects of CSF-1R D802V and KIT D816V homologous mutations on receptor tertiary structure and allosteric communicationPlatelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes.Differences in growth promotion, drug response and intracellular protein trafficking of FLT3 mutants.Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages.
P2860
Q24685013-9F7091ED-8DE2-4459-8782-D797F03BF090Q28472613-CA92FB02-B1BD-4B72-8C53-427A6A77CAFCQ28548625-6758794D-E2EF-4A09-AB32-86E316FFDFA8Q28553167-5736E7B4-6728-461B-B3DC-92483F916654Q28589492-506D6D88-C78A-4165-A86C-59643BAAD3ADQ33274781-DB0465FE-8F5C-4DD3-829E-7C9FB51273D2Q33615748-3D47126F-BD09-4DF2-B14D-A851A2EDB17FQ33902070-DF7AAFB5-2D5E-4C48-A5C0-3AE770740A42Q34028872-A8773A04-A5DE-4AB6-8B3F-5F85554E5D8EQ34577769-88758E62-DFE2-41EA-984C-C4D2383DB7E9Q35168745-286357C0-D771-439C-987D-7285DAF719E7Q41183542-61C4F11B-0430-42BD-BA31-AB3A0580D6FAQ41760980-3CD2AD81-3429-49B4-83D3-B1E96C5694D2Q42408332-29299740-F77A-4C91-9B9B-4D6BAD4DFD8BQ48136572-13367869-0165-4680-963A-023CF26334CE
P2860
FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
FMS receptor for M-CSF (CSF-1) ...... 802 to Val confers resistance.
@en
type
label
FMS receptor for M-CSF (CSF-1) ...... 802 to Val confers resistance.
@en
prefLabel
FMS receptor for M-CSF (CSF-1) ...... 802 to Val confers resistance.
@en
P2093
P356
P1433
P1476
FMS receptor for M-CSF (CSF-1) ...... -802 to Val confers resistance
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1209007
P407
P577
2006-01-01T00:00:00Z
P5875
P6179
1007897425